Insulin of glargine U300 - a Basal Insulin in the next Generation

被引：0
|
作者：
Luger, A. [1 ]
机构：
[1] Med Univ Wien, Univ Klin Innere Med 3, Klin Abt Endokrinol & Stoffwechsel, Wahringer Gurtel 18-20, A-1090 Vienna, Austria
来源：
AUSTRIAN JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM | 2015年 / 8卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：66 / 68
页数：3
相关论文
共 50 条
  • [1] Insulin glargine U300 Approved Basal Insulin is now three times concentrated
    Forst, Thomas
    [J]. DIABETES STOFFWECHSEL UND HERZ, 2016, 25 (02): : 4 - 6
  • [2] Versatile Insulin glargine U300 in daily Practice
    不详
    [J]. DIABETES STOFFWECHSEL UND HERZ, 2016, 25 (02): : 7 - 8
  • [3] rDNA insulin glargine U300 - a critical appraisal
    Wang, Fei
    Zassman, Stefanie
    Goldberg, Philip A.
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2016, 9 : 425 - 441
  • [4] Diabetic Ketoacidosis Occurring in Patient on Newly Started Insulin Glargine U300
    Kirac, Cem Onur
    Ipekci, Suleyman Hilmi
    Kebapcilar, Levent
    [J]. EUROPEAN JOURNAL OF THERAPEUTICS, 2018, 24 (04): : 266 - 267
  • [5] CONFIRM: a comparative effectiveness study of insulin degludec and insulin glargine 300 units/ ml (glargine U300) in insulin-naive patients with type 2 diabetes
    Tibaldi, J.
    Haldrup, S.
    Sandberg, V.
    Wolden, M. L.
    Rodbard, H. W.
    [J]. DIABETOLOGIA, 2018, 61 : S44 - S44
  • [6] Pharmacodynamic and pharmacokinetic evaluation of insulin glargine U300 for the treatment of type 1 diabetes
    Hurren, Kathryn M.
    O'Neill, Jessica L.
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (12) : 1521 - 1526
  • [7] Titration when switching from insulin degludec to insulin glargine U300 among Japanese diabetes patients
    Ishikawa, Takuya
    Kato, Tomotaka
    Iijima, Yasuhiro
    Sakurai, Mamoru
    Shikuma, Jumpei
    Ito, Rokuro
    Sakai, Hiroyuki
    Hara, Kazuo
    Miwa, Takashi
    Kanazawa, Akira
    Odawara, Masato
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S108 - S108
  • [8] Innovations in Insulin: Insulin Glargine U-300
    Anderson, John E.
    [J]. JOURNAL OF FAMILY PRACTICE, 2016, 65 (10): : S23 - S28
  • [9] PREDICTION OF HYPOGLYCEMIA IN PATIENTS TREATED WITH INSULIN GLARGINE 300 U/ML FOR BASAL INSULIN THERAPY
    Takeishi, S.
    Inoue, T.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A176 - A177
  • [10] Switching to insulin glargine 300 U/mL: Is duration of prior basal insulin therapy important?
    Bonadonna, Riccardo C.
    Renard, Eric
    Cheng, Alice
    Fritsche, Andreas
    Cali, Anna
    Melas-Melt, Lydie
    Umpierrez, Guillermo E.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 142 : 19 - 25
12345